Compound 1415
Identifiers
- Canonical SMILES:
FC(F)(F)c1c(Sc2cccc(NC3CCS(=O)(=O)CC3)c2)ccc(\C=C\C(=O)N2CCOCC2)c1C(F)(F)F
- IUPAC name:
(E)-3-[4-[3-[(1,1-dioxothian-4-yl)amino]phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-ylprop-2-en-1-one
- InChi:
InChI=1S/C26H26F6N2O4S2/c27-25(28,29)23-17(5-7-22(35)34-10-12-38-13-11-34)4-6-21(24(23)26(30,31)32)39-20-3-1-2-19(16-20)33-18-8-14-40(36,37)15-9-18/h1-7,16,18,33H,8-15H2/b7-5+
- InChiKey:
WMEFWYNKCHWYAA-FNORWQNLSA-N
External links
![]() 59006916 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| LFA / ICAM | 8.22 | immune system disease | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 608.12 g/mol | |||
| HBA | 6 | |||
| HBD | 1 | |||
| HBA + HBD | 7 | |||
| AlogP | 3.82 | |||
| TPSA | 75.71 | |||
| RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.7800 | 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline | DB07486 | |
| 0.4072 | Bicalutamide | DB01128 | |
| 0.4072 | (R)-Bicalutamide | DB02932 | |
| 0.3904 | 5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide | DB07180 | |
| 0.3778 | Henatinib | DB13019 | |
| 0.3769 | Semaxanib | DB06436 | |
| 0.3766 | SU-11652 | DB08009 | |
| 0.3694 | Orantinib | DB12072 | |
| 0.3682 | 3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE | DB08577 | |
| 0.3632 | Flupentixol | DB00875 | |
| 0.3610 | Sunitinib | DB01268 | |
| 0.3490 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | DB08039 | |
| 0.3487 | Elobixibat | DB12486 | |
| 0.3475 | Vorolanib | DB15247 | |
| 0.3467 | Idrocilamide | DB13297 |




